While governments around the world pour taxpayers' money into a whole range of supposedly win-win "green investments", this paper finds that these waste resources and reduce economic growth without necessarily protecting the environment.

The HIV / AIDS crisis bears a number of clinical and practical similarities to the new challenge of producing drugs to treating chronic disease in lower-income countries, providing a useful case study when determining effective strategies. A new literature review by Philip Stevens, the second in a three-part series, examines what can be learned from the global response to HIV / AIDS – and reveals some costly mistakes that should not be repeated.

Counterfeit and substandard medicines are still harming the reputation of the Indian pharmaceutical industry and endangering the wellbeing of patients, according to a recent survey.

The European Union is funding some of the most powerful environmental NGOs in Brussels – while in turn, they lobby the EU for more money and influence.